The Second Affiliated Hospital of Kunming Medical University is a large general hospital in the capital of Yunnan Province, China. Established in 1952, it is among the "100 best general hospitals of China" and is the center for both human organ transplant and burn treatment in Yunnan.

There are 1,500 beds in The Second Affiliated Hospital of Kunming Medical University.

During the past decade, The Second Affiliated Hospital of Kunming Medical University conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Kunming Medical University" #1 sponsor was "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "The Second Affiliated Hospital of Kunming Medical University" with 2 trials sponsored, "Zensun Sci. & Tech. Co., Ltd." with 2 trials sponsored and "Air Force Military Medical University, China" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Kunming Medical University" #1 collaborator was "The Second Affiliated Hospital of Kunming Medical University" with 4 trials as a collaborator, "The Second Hospital of Hebei Medical University" with 3 trials as a collaborator, "Anhui Provincial Children's Hospital" with 2 trials as a collaborator, "First Affiliated Hospital of Kunming Medical University" with 2 trials as a collaborator and "Henan Provincial People's Hospital" with 2 trials as a collaborator. Other collaborators include 128 different institutions and companies that were collaborators in the rest 135 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Kunming Medical University" are "Acute Migraine" (2 trials), "Chronic Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials) and "Adenocarcinoma of the Lung" (1 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Kunming Medical University" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Kunming Medical University" are "Drug" (22 trials), "Biological" (3 trials), "Other" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "rhNRG-1" (2 trials), "Abelmoschus manihot" (1 trials), "Abelmoschus manihot (AM)" (1 trials) and "Abiraterone acetate tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Kunming Medical University" are 25 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "The Second Affiliated Hospital of Kunming Medical University". 2 are not yet recruiting, 11 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Second Affiliated Hospital of Kunming Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Kunming Medical University, 6 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".